Cardiovascular Systems Analysis
Cardiovascular Systems holds a debt-to-equity ratio of 0.088. With a high degree of financial leverage come high-interest payments, which usually reduce Cardiovascular Systems' Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Cardiovascular Systems' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Cardiovascular Systems' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Cardiovascular Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Cardiovascular Systems' stakeholders.
For most companies, including Cardiovascular Systems, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Cardiovascular Systems, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Cardiovascular Systems' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Cardiovascular Systems' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Cardiovascular Systems is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Cardiovascular Systems to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Cardiovascular Systems is said to be less leveraged. If creditors hold a majority of Cardiovascular Systems' assets, the Company is said to be highly leveraged.
Cardiovascular Systems is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cardiovascular Systems delisted stock analysis is to determine its intrinsic value, which is an estimate of what Cardiovascular Systems is worth, separate from its market price. There are two main types of Cardiovascular Systems' stock analysis: fundamental analysis and technical analysis.
The Cardiovascular Systems stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cardiovascular Systems' ongoing operational relationships across important fundamental and technical indicators.
Cardiovascular |
Cardiovascular Stock Analysis Notes
About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Cardiovascular Systems was currently reported as 5.7. The company has Price/Earnings (P/E) ratio of 724.24. Cardiovascular Systems recorded a loss per share of 0.96. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 26th of February 2009. Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people. For more info on Cardiovascular Systems please contact the company at 651 259 1600 or go to https://www.csi360.com.Cardiovascular Systems Investment Alerts
| Cardiovascular Systems is not yet fully synchronised with the market data | |
| Cardiovascular Systems has some characteristics of a very speculative penny stock | |
| Cardiovascular Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M. | |
| Cardiovascular Systems currently holds about 159.83 M in cash with (24.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
Cardiovascular Systems Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cardiovascular Systems previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of May 2023 Upcoming Quarterly Report | View | |
| 1st of August 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 1st of August 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Cardiovascular Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 843.96 M.Cardiovascular Profitablity
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.Cardiovascular Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardiovascular Systems insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardiovascular Systems' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardiovascular Systems insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott Ward over a year ago Disposition of 578310 shares by Scott Ward of Cardiovascular Systems subject to Rule 16b-3 |
Cardiovascular Systems Outstanding Bonds
Cardiovascular Systems issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardiovascular Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardiovascular bonds can be classified according to their maturity, which is the date when Cardiovascular Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Cardiovascular Systems Debt to Cash Allocation
As Cardiovascular Systems follows its natural business cycle, the capital allocation decisions will not magically go away. Cardiovascular Systems' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.Cardiovascular Systems Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cardiovascular Systems' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cardiovascular Systems, which in turn will lower the firm's financial flexibility.Cardiovascular Systems Corporate Bonds Issued
Most Cardiovascular bonds can be classified according to their maturity, which is the date when Cardiovascular Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cardiovascular Systems to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |